ivonescimab
akesobio
['sclc', 'ak112', 'ivonescimab', 'nsclc', 'akeso']
#akeso releases promising data of #ivonescimab (#pd1 #vegf #bsabs #ak112) for advanced #nsclc at #asco22 
Follow top-line development in the oncology commercial domain. Gain entry to KOL discussions, including both medical professionals and business leaders.